← Human Trials & Peer-Reviewed Studies

A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status.

Plain-language guide to PMID 11916759 (2002): double-blind controlled clinical trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
11916759
Journal
The American journal of clinical nutrition
Year
2002
Study type
Controlled Clinical Trial
Authors
Karyadi E et al. (9 authors)
DOI
10.1093/ajcn/75.4.720

What This Study Did, in Plain Language

What Was Tested

This controlled clinical trial looks at Vitamin D, K2, Magnesium and Zinc.

The results of cross-sectional studies indicate that micronutrient deficiencies are common in patients with tuberculosis.

No published data exist on the effect of vitamin A and zinc supplementation on antituberculosis treatment.

Who Took Part

The age groups tagged for this paper are teenagers, adults and middle-aged adults, both men and women.

In this double-blind, placebo-controlled trial, patients with newly diagnosed tuberculosis were divided into 2 groups.

Both groups received the same antituberculosis treatment recommended by the World Health Organization.

How the Study Was Run

The researchers set it up as a double-blind and placebo-controlled study.

Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

The second group (n = 40) received a placebo.

Clinical examinations, assessments of micronutrient status, and anthropometric measurements were carried out before and after 2 and 6 mo of antituberculosis treatment.

What Was Measured

Topics PubMed links to this paper include Anthropometry, Antitubercular Agents, Body Mass Index, Case-Control Studies, Drug Synergism, Indonesia and Nutritional Status.

What This Means in Plain Language

The paper is a double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2002 (The American journal of clinical nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.